Maxion Therapeutics doubles R&D space at Unity Campus after £58 million Series A fundraise
Making a difference in the local community
Charity Easter Egg Campaign 2025
Papworth Trust joins Unity Campus
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
Howard Group drives growth of South Cambridge’s life sciences ecosystem with new Unity Campus deal
Collaboration: A key component in successful project delivery
Unity Campus wins award for excellence in community building
Transforming to Zero - Changing Behaviours to Decarbonise Laboratories: Unity Campus
Groundbreaking nanomedicine company ViaNautis lands at Unity Campus
Inside Unity Campus: in conversation with Alex Searle, Facilities & Operations Administrator
Innovative nanomedicine company, ViaNautis is the latest biotech to join the impressive line-up at Howard Group’s prestigious Unity Campus
Unlocking lab space: Challenges and solutions for life science scale-ups
Welbeck Health Partners signs 30-year lease at Unity Campus, signalling leap towards integrated patient care and R&D in South Cambridge
Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO
Inside Unity Campus: in conversation with Jess Harvey-Bowman, Community Engagement Manager
Unity Campus unites for a festive cause
FutureIN wins Apprenticeship Initiative of the Year at Construction News Workforce Awards 2023
Cambridge cluster on road to Net Zero
